US11844799B2 | 19 December 2023 | Grant | US17745045 | Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic | Actinium Pharmaceuticals Inc |
---|
US11807314B2 | 7 November 2023 | Grant | US17726299 | Steering device and steering unit device | Actinium Pharmaceuticals Inc |
---|
US11406724B2 | 9 August 2022 | Grant | US16298202 | Stabilized radiolabeled anti-cd45 immunoglobulin compositions | Actinium Pharmaceuticals Inc |
---|
US11364235B2 | 21 June 2022 | Grant | US16607168 | Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic | Actinium Pharmaceuticals Inc |
---|
US11292835B2 | 5 April 2022 | Grant | US16300672 | Low dose antibody-based methods for treating hematologic malignancies | Actinium Pharmaceuticals Inc |
---|